Trials / Recruiting
RecruitingNCT04086290
National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
Oligomet-DK. National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Peter Busch Østergren · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, open label phase 2 clinical trial assessing safety, complications and feasibility of radical prostatectomy (RARP) plus local stereotactic body radiotherapy (SBRT) to bone metastases in combination with short-term medical castration to a select population of prostate cancer patients with oligometastatic disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | RARP | Radical prostatectomy + extended pelvic lymph node dissection |
| RADIATION | SBRT | Stereotactic body radiotherapy to osseous lesions |
| DRUG | ADT | six month of neo-adjuvant/concomitant medical castration therapy using a gonadotropin-releasing hormone antagonist or agonist. |
Timeline
- Start date
- 2019-10-10
- Primary completion
- 2023-10-01
- Completion
- 2028-10-01
- First posted
- 2019-09-11
- Last updated
- 2020-02-12
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04086290. Inclusion in this directory is not an endorsement.